Overview

Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen

Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
To investigate the comparative tolerability, metabolism and pharmacokinetics of individual enantiomers of PQ in healthy human volunteers, receiving study drug over the course of 7 days.
Phase:
Phase 1
Details
Lead Sponsor:
University of Mississippi, Oxford
Treatments:
Primaquine